Advance Nanotech Announces Shareholder Proxy Vo...(detection. Its proprietary technologies ...)
| HOME >> BIOLOGY >> TECHNOLOGY |
detection. Its proprietary technologies are uniquely silicon based thus offering the benefits of miniaturization and network capability. The core detector allows for real-time precision analytics leading to potential prevention of ensuing issues, concerns and dangers. Through its majority owned subsidiary, Owlstone Nanotech, Advance Nanotech has 1 recently awarded patent and 18 patent pending applications. For more information on Advance Nanotech, please visit http://www.advancenanotech.com.
The information contained in this news release, other than historical
information, consists of forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange Act.
These statements may involve risks and uncertainties that could cause
actual results to differ materially from those described in such
statements. Although the Company believes that the expectations reflected
in such forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Important factors,
including general economic conditions, spending levels, market acceptance
of product lines, the recent economic slowdown affecting technology
companies, the future success of scientific studies, ability to
successfully develop products, rapid technological change, changes in
demand for future products, legislative, regulatory and competitive
developments and other factors could cause actual results to differ
materially from the Company's expectations. Advance Nanotech's Annual
Report on Form 10KSB, recent and forthcoming Quarterly Reports on Form
10QSB, recent Current Reports and other SEC filings discuss some of the
important risk factors that may affect Advance Nanotech's business, results
of operations and financial condition. The Company undertakes no obligation
to revise or update publicly any forward-looking statements for any reason.
<
'/>"/>
| SOURCE Advance Nanotech, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. KGI Names Kerry Howell Vice President for Advancement
3. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
4. Advanced Cell Technology Announces Proposed Financing
5. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
6. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
7. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
8. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
9. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
10. Microfluidic chambers advance the science of growing neurons
11. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |